Dr. Jesus Manuel Salas Noain, MD

Dr. Salas Noain practices at St. Augustine Endoscopy Center in Saint Augustine, Florida.

Dr. Salas Noain's NPI, 1003360645, was assigned on August 11, 2016. Dr. Salas Noain graduated from University of San Martin de Porres Faculty of Medicine in 2014. Dr. Salas Noain holds Florida license ME165328.

Dr. Salas Noain's primary practice is St. Augustine Endoscopy Center, at 40 Groover Loop Suite 100, Saint Augustine, FL 32086. The practice phone is (904) 824-6108.

Dr. Salas Noain's primary practice is St. Augustine Endoscopy Center in Saint Augustine, Florida. Dr. Salas Noain is also affiliated with UF Health Flagler Hospital. The medical group on file is Borland Groover. Dmand AI also links Dr. Salas Noain to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salas Noain practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Salas Noain's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Salas Noain is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Salas Noain's licenses on file in 2 states: Florida and Pennsylvania.

CMS data shows 226 Medicare services from Dr. Salas Noain across 7 procedure codes in 2024, for 128 Medicare patients. Medicare paid $23,599 for them.

CMS counts 128 Medicare patients who saw Dr. Salas Noain in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Salas Noain's median patient age at 63, with 52% women.

In 2024, Dr. Salas Noain wrote 145 Medicare Part D claims for 73 patients. 83% of them were for generic drugs. CMS names the drug for 81 of them, across 3 drugs with 11 or more claims each, at $17,229 in total drug cost. In 2023, CMS named 21 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Salas Noain for performance year 2024, reported as part of a group. Dr. Salas Noain accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Salas Noain as offering telehealth. CMS counts 119 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Salas Noain, more than 80% of the clinicians it reports for that procedure.

CMS Open Payments shows 47 general payments to Dr. Salas Noain from 13 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $518.

Dr. Salas Noain graduated from University of San Martin de Porres Faculty of Medicine in 2014.

Dr. Salas Noain is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.